CORRESP Filing
REVELATION BIOSCIENCES, INC.
Date: May 23, 2025 · CIK: 0001810560 · Accession: 0001213900-25-047306
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287423
Letter
J.P. Galda & Co.
40 East Montgomery Avenue, LTW 220
Ardmore, Pennsylvania 19008
May 23, 2025
VIA EDGAR AND E-MAIL
Mr. Alan Campbell
Mr. Joseph McCann
Office of Life Sciences
Division of Corporate Finance
U.S. Securities and Exchange Commission
100 F. Street, N.E.
Washington, DC 20549-7010
Re: Revelation Biosciences, Inc. Registration Statement on Form S-1
Commission File No. 333-287423
Gentlemen:
This letter will confirm my conversation with Mr. McCann to the effect that we are not individually responding to the Staff's letter of comments on the above-captioned Registration Statement because the transaction has been restructured to eliminate the zero exercise price warrants and the Class H-3 Common Stock Warrants, thereby rendering such comments no longer applicable.
Very truly yours,
/s/ Joseph P. Galda
Show Raw Text
CORRESP 1 filename1.htm J.P. Galda & Co. 40 East Montgomery Avenue, LTW 220 Ardmore, Pennsylvania 19008 May 23, 2025 VIA EDGAR AND E-MAIL Mr. Alan Campbell Mr. Joseph McCann Office of Life Sciences Division of Corporate Finance U.S. Securities and Exchange Commission 100 F. Street, N.E. Washington, DC 20549-7010 Re: Revelation Biosciences, Inc. Registration Statement on Form S-1 Commission File No. 333-287423 Gentlemen: This letter will confirm my conversation with Mr. McCann to the effect that we are not individually responding to the Staff's letter of comments on the above-captioned Registration Statement because the transaction has been restructured to eliminate the zero exercise price warrants and the Class H-3 Common Stock Warrants, thereby rendering such comments no longer applicable. Very truly yours, /s/ Joseph P. Galda